IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Lifted by Donoghue Forlines LLC

Donoghue Forlines LLC increased its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXXGet Rating) by 5.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,945 shares of the company’s stock after buying an additional 152 shares during the quarter. Donoghue Forlines LLC’s holdings in IDEXX Laboratories were worth $1,939,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. EverSource Wealth Advisors LLC bought a new position in IDEXX Laboratories during the 4th quarter worth $28,000. Bell Investment Advisors Inc bought a new position in shares of IDEXX Laboratories in the third quarter worth $34,000. Institutional & Family Asset Management LLC grew its stake in shares of IDEXX Laboratories by 216.7% in the third quarter. Institutional & Family Asset Management LLC now owns 57 shares of the company’s stock worth $35,000 after purchasing an additional 39 shares in the last quarter. Exane Derivatives bought a new position in shares of IDEXX Laboratories in the fourth quarter worth $40,000. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of IDEXX Laboratories in the third quarter worth $42,000. Hedge funds and other institutional investors own 84.92% of the company’s stock.

IDXX has been the subject of several recent analyst reports. Bank of America cut IDEXX Laboratories from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $550.00 to $470.00 in a research note on Thursday, May 5th. Atlantic Securities initiated coverage on IDEXX Laboratories in a research note on Tuesday, February 8th. They issued an “overweight” rating and a $650.00 price target for the company. William Blair reissued an “outperform” rating on shares of IDEXX Laboratories in a research note on Wednesday, February 2nd. Finally, StockNews.com cut IDEXX Laboratories from a “buy” rating to a “hold” rating in a research note on Friday, May 6th. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, IDEXX Laboratories has an average rating of “Buy” and an average price target of $663.67.

IDXX stock traded up $4.90 during trading hours on Tuesday, hitting $365.10. 21,135 shares of the stock traded hands, compared to its average volume of 895,797. IDEXX Laboratories, Inc. has a one year low of $330.66 and a one year high of $706.95. The company has a market cap of $30.67 billion, a P/E ratio of 42.23, a P/E/G ratio of 2.31 and a beta of 1.10. The company has a current ratio of 1.12, a quick ratio of 0.81 and a debt-to-equity ratio of 1.21. The stock has a 50-day simple moving average of $484.08 and a 200 day simple moving average of $541.86.

IDEXX Laboratories (NASDAQ:IDXXGet Rating) last announced its earnings results on Wednesday, May 4th. The company reported $2.27 EPS for the quarter, beating the consensus estimate of $2.25 by $0.02. IDEXX Laboratories had a return on equity of 103.70% and a net margin of 22.43%. The business had revenue of $836.55 million during the quarter, compared to the consensus estimate of $836.47 million. During the same period in the prior year, the business posted $2.35 earnings per share. IDEXX Laboratories’s revenue was up 7.6% compared to the same quarter last year. Analysts forecast that IDEXX Laboratories, Inc. will post 8.24 earnings per share for the current year.

About IDEXX Laboratories (Get Rating)

IDEXX Laboratories, Inc develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Featured Stories

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.